Dynavax Technologies Corporation (LON:0IDA)
9.86
-0.27 (-2.65%)
At close: Jul 1, 2025
Dynavax Technologies Revenue
Dynavax Technologies had revenue of $68.16M USD in the quarter ending March 31, 2025, with 34.21% growth. This brings the company's revenue in the last twelve months to $294.62M, up 24.76% year-over-year. In the year 2024, Dynavax Technologies had annual revenue of $277.25M with 19.36% growth.
Revenue (ttm)
$294.62M
Revenue Growth
+24.76%
P/S Ratio
3.96
Revenue / Employee
$727.46K
Employees
405
Market Cap
903.07M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 277.25M | 44.96M | 19.36% |
Dec 31, 2023 | 232.28M | -490.40M | -67.86% |
Dec 31, 2022 | 722.68M | 283.24M | 64.45% |
Dec 31, 2021 | 439.44M | 399.19M | 991.75% |
Dec 31, 2020 | 40.25M | 5.03M | 14.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Dynavax Technologies News
- 22 days ago - Dynavax re-elects all board members, despite Deep Capital's push to change - Seeking Alpha
- 22 days ago - Dynavax elects all four of its nominees after Deep Track proxy fight - Reuters
- 22 days ago - Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting - PRNewsWire
- 24 days ago - Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom - Business Wire
- 24 days ago - Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting - PRNewsWire
- 4 weeks ago - Dynavax responds to proxy advisor calling for board change - Seeking Alpha
- 4 weeks ago - Dynavax Comments on Glass Lewis Recommendation - PRNewsWire
- 4 weeks ago - Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies - Business Wire